| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $118.4M | +18.9% |
| Cost of Revenue | $86.4M | +29.4% |
| R&D Expense | $4.7M | -8.9% |
| SG&A Expense | $22.3M | +40.3% |
| Operating Income | -$4.7M | -113.7% |
| Pre-tax Income | -$13.2M | -32.5% |
| Income Tax | $118K | +81.5% |
| Net Income | -$12.0M | -19.4% |
| EPS (Basic) | -$0.14 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -16.9% |
| Accounts Receivable | $13.2M | -3.3% |
| Inventory | $1.8M | -30.6% |
| Current Assets | $24.3M | -12.2% |
| Total Assets | $63.9M | -3.1% |
| Current Liabilities | $46.8M | +5.3% |
| Total Liabilities | $57.3M | -7.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.8M | +278.2% |
| Capital Expenditures | $3.0M | +24.6% |
| Investing Cash Flow | -$4.0M | -65.1% |
| Financing Cash Flow | -$4.3M | -341.0% |
| Free Cash Flow | $3.8M | +160.7% |
| -16.7% |
| Stockholders' Equity |
| -$8.7M |
| -763.2% |